Allena Pharmaceuticals Inc (ALNA) Stock
ALNA is no longer traded. Allena Pharmaceuticals was delisted from the Nasdaq in November 2022.
Prices on this page are historical; the last trade was November 9, 2022 at $0.01.
Allena Pharmaceuticals stock price history
ALNA final trading statistics
- Final close
- $0.01
- Final trading day
- Nov 9, 2022
- Market cap at delisting
- $9.16M
- Shares outstanding
- 122.08M
- Final 52-week range
- $0.01 – $0.94
- Avg. volume (final 3 mo.)
- 8,234,227
- All-time high (split-adj.)
- $16.60 · Apr 2018
- All-time low (split-adj.)
- $0.01 · Nov 2022
- Return since IPO
- -99.9%
- Beta
- 1.15
- Book value / share
- $0.04
- Price / book
- 0.32
Allena Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $0.00 | -$32.8M | -$0.73 |
| FY2020 | $0.00 | -$32.8M | -$1.03 |
| FY2019 | $0.00 | -$47.3M | -$2.13 |
| FY2018 | $0.00 | -$35.6M | -$1.72 |
| FY2017 | $0.00 | -$21.6M | -$5.17 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Allena Pharmaceuticals Inc
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.
Allena Pharmaceuticals stock FAQ
What happened to Allena Pharmaceuticals stock?
Allena Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $0.01 on November 9, 2022.
Is ALNA stock still trading?
No. ALNA was delisted from the Nasdaq in November 2022 and no longer trades on a U.S. exchange.
What was the last price of ALNA stock?
ALNA closed at $0.01 on its final trading day, November 9, 2022, for a market value of about $9.16M.
What were Allena Pharmaceuticals's revenue and earnings in its last full fiscal year?
Allena Pharmaceuticals reported revenue of $0.00 and net income of -$32.8M in fiscal 2021, its last full year as a public company.
When did Allena Pharmaceuticals go public?
Allena Pharmaceuticals Inc stock began trading on November 2, 2017.